Cargando…
The blood-brain barrier in Alzheimer's disease
Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by the pathological accumulation of amyloid beta (Aβ) peptides and neurofibrillary tangles containing hyperphosphorylated neuronal tau protein. AD pathology is also characterized by chronic brain inflammation, which...
Autores principales: | Zenaro, Elena, Piacentino, Gennj, Constantin, Gabriela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600438/ https://www.ncbi.nlm.nih.gov/pubmed/27425887 http://dx.doi.org/10.1016/j.nbd.2016.07.007 |
Ejemplares similares
-
Blockade of α4 integrins reduces leukocyte–endothelial interactions in cerebral vessels and improves memory in a mouse model of Alzheimer’s disease
por: Pietronigro, Enrica, et al.
Publicado: (2019) -
Imaging of Leukocyte Trafficking in Alzheimer’s Disease
por: Pietronigro, Enrica, et al.
Publicado: (2016) -
NETosis in Alzheimer’s Disease
por: Pietronigro, Enrica Caterina, et al.
Publicado: (2017) -
Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease
por: Rossi, Barbara, et al.
Publicado: (2021) -
Blood–brain-barriers in aging and in Alzheimer’s disease
por: Marques, Fernanda, et al.
Publicado: (2013)